pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 30·1 min read
save

Trump administration abandons Biden Ebola response plan, opting for new strategy

May 30, 2026·read at STAT ↗RegulatoryNegative

The Biden administration completed a multi-hundred-page set of guidelines in early 2025 outlining how federal agencies should handle future disease threats, including protocols for Ebola outbreaks and repatriation of patients.

According to two former CDC officials who served under the current administration, the Trump team has chosen to set aside those detailed instructions and pursue its own approach.

Industry observers note that the departure from the established playbook could complicate coordination between government and pharmaceutical firms developing vaccines and treatments for emerging infections.

The change adds uncertainty to the nation’s preparedness framework, raising questions about the speed and effectiveness of future outbreak responses.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: As Ebola outbreak grows, Trump administration veers from previous government playbook”

read at STAT ↗
546 words · retrieved Jun 2
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
Obesity
topics
ObesityVaccines

related stories

  • Jun 30Half of states sue over Medicaid work requirementsSTAT
  • Jun 30STAT+: Even with MAHA, Trump administration has gone soft on alcoholSTAT
  • Jun 17STAT+: A prominent VC explains why she’s against U.S. restrictions on investment in China’s drug industrySTAT
  • Jun 16Lilly buys non-opioid pain drugmaker 4EBioPharma Dive
  • Jun 16STAT+: ARCH-launched Neumora stops depression programSTAT